Skip to main content

Featured

Fifteen Lives Lost in Tragic Boat Collision Off Chios

Greek emergency personnel wait to transfer bodies of dead migrants, following migrant’s boat collision with coast guard off the island of Chios, in the port of Chios, Greece, February 3, 2026. A deadly maritime collision near the Greek island of Chios has left fifteen migrants dead and prompted urgent questions about how the incident unfolded. According to early reports, a migrant vessel carrying dozens of people struck a Hellenic Coast Guard patrol boat during the night, causing the smaller craft to overturn. Rescue teams recovered multiple bodies from the water while continuing to search the surrounding area for any additional survivors. Twenty‑five people were pulled from the sea alive, several of whom were transported to local hospitals for treatment. Authorities have opened an investigation to determine the sequence of events leading up to the crash, including the movements of both vessels and the conditions at the time. The tragedy adds to the growing concerns over the dangers...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment